Healthcare Roundup – T2 Biosystems launches COVID-19 molecular diagnostic test, CytoDyn down 32% Life Science
Healthcare Roundup – Gilead prices remdesivir at $390 per vial, RedHill Biopharma to launch late-stage study of opaganib in COVID-19 Life Science
Healthcare Roundup – European advisory backs Gilead’s remdesivir for COVID-19, Ekso Bionics shares rocket Life Science
Healthcare Roundup – UniQure out-licenses hemophilia B gene therapy, Bad COVID news is good news for COVID vaccine & drugmakers Life Science
Healthcare Roundup – AstraZeneca up modestly on positive COVID-19 vaccine news, Pot stocks rally on Aurora Cannabis reboot actions Life Science
Healthcare Roundup – FDA OKs new formulation of Regeneron and Sanofi’s Dupixent, COVID blows keep coming – Phillies close training facilities Life Science
Healthcare Roundup – AbbVie nixes microbiome GI program collaboration, Alpha Pro Tech pops Life Science
Healthcare Roundup – FDA yanks emergency use authorization of Chembio COVID-19 blood test, Gilead readies pediatric study of remdesivir Life Science
Healthcare Roundup – COVID-19 treatment, economic news push futures even higher, COVID hospitalizations on the rise in Texas Life Science
Healthcare Roundup – CDC warns on another round of lockdowns, AbbVie thumbs down on discounted mini-tender for shares Life Science
Healthcare Roundup – Delta aims to test all employees for COVID-19, CVS Health opens 10 drive-thru COVID-19 test sites Life Science
Healthcare Roundup – States go after generic drugmakers for alleged price-fixing, Lilly’s COVID-19 treatment maybe available as soon as September Life Science
CANbridge Pharmaceuticals Enters Into Rare Disease Gene Therapy Research Agreement With UMass Medical School Life Science
